Organizing Committee
OCM Member
Professor and Consultant Neurologist, Neurology
King Saud University , Saudi Arabia
Research Interest :

Neuro examination,Alzheimer's, Multiple Sclerosis and Diabetic Neuropathy

OCM Member
Eastern Virginia Medical School , USA
Research Interest :

Neuroscience

OCM Member
Medical Director
Deep Brain Stimulation Program UC Davis Health System , USA
Biography :

As a fellowship-trained neurologist subspecializing in movement disorders, Dr. Zhang’s primary clinical and research interests are in Parkinson's disease (PD), tremor, ataxia, and other movement disorders. His particular expertise has led him to focus on the epidemiology of PD, exploring whether nutritional deficiencies in certain populations have an impact on PD. He currently serves as Chair of the Working Group on Genetic & Environmental Risk Factors for PD as part of the largest clinical research consortium in the country, the Parkinson Study Group (PSG). As a member site for PSG, the clinical trial program he leads at UC Davis has participated in many multicenter trials testing new medications for PD, several of which are now used in clinical practice. Dr. Zhang’s other clinical and research interests focus on dystonia and related movement disorders such as facial spasm, limb spasticity, and dystonic tremor, all of which can be treated with neurotoxin injections, most commonly botox. He has participated in registry studies and double-blinded clinical trials for neurotoxin therapeutics, and his services presently offer four different types of neurotoxins to accommodate the patient's needs, symptoms, previous exposure to other toxins, and a variety of other indications. Dr. Zhang also serves as the medical director of the Deep Brain Stimulation (DBS) program at UC Davis and he is very interested in the clinical applications of DBS. Under his direction the DBS program of UCDavis has become a referral center that offers implantation surgery weekly and clinical programming visits daily, serving the greater Sacramento area and northern California.

Research Interest :

Deep Brain Stimulation

OCM Member
Professor, Neurology
Moscow Helmholtz Research Institute of Eye Diseases , Russia
Biography :

Professor of Pathophysiology Marina Zueva graduated from the Lomonosov Moscow State University (Physiology of Higher Nervous Activity). She received her Ph.D. degree in 1980 and then the degree of Doctor of Biol Sci in 1997 from Moscow Helmholtz Research Institute of Eye Diseases. From 1973 to present time she works in the Department of Clinical Physiology of Vision at Moscow Helmholtz Research Institute of Eye Diseases. Current position - the Head of the Department. In 2017, she founded and became a General Director of the LTD “Center of Neurocognitive Technologies “Cognito”.” Marina Zueva is a member of International Society of Clinical Electrophysiology of Vision (ISCEV), European Association for Vision and Eye Research (EVER), European Society of Retina Specialists (EURETINA) and some other scientific Societies. She has published over 15 peer-reviewed papers in English and over 100 in Russian, 13 Chapters in the books (one – in English) and presented over 70 topics at international conferences. Research Topics: Basic and clinical physiology and electrophysiology of vision, neurophysiology; Age-related, developmental and neurodegenerative disorders of the visual system and brain, neurocognitive technologies in the diagnosis and treatment of diseases of the retina and brain.

Research Interest :

Alzheimer's Disease and Dementia

OCM Member
Spanish National Research Council-University of Seville , Spain
Research Interest :

Alzheimer's Disease and Dementia

OCM Member
Fraunhofer Institute for Ceramic Technologies and Systems , Germany
Biography :

Hannes Richter is Head of the Department of “Nanoporous Membranes”. For his thesis on ceramic nanofiltration membranes (1998), he received the Bernhard-von-Cotta Award of the Freiberg University. He is experienced in amorphous membranes for 20 years and in zeolite and carbon membranes for more than 10 years. For the development of NaA-membranes and its scaling-up in to an industrial level, he received the Exceptional price of “Junior Scientist Award” competition at Materialsweek 2004, the “Innovation Award Middle Germany 2008 - Cluster Energy and Environment” and “Innovation Award Energy 2009” of the Society for the Promotion of Renewable Energy. For the development of ceramic nanofiltration membranes with a cut-off of 200 Da, he won the “Fraunhofer Award 2017”. He is the author of about 38 papers, gave more than 70 lectures in national and international congresses, thereof 26 invited presentations and is inventor of 8 patents.

Research Interest :

Alzheimer's Disease and Dementia

OCM Member
University of Padua , Italy
Biography :

Stephen D. Skaper received a PhD in biochemistry from the University of South Dakota and Laurea in chemistry from the University of Padua, Italy. He is currently Adjunct Professor in the Department of Pharmaceutical and Pharmacological Sciences (section on Pharmacology and Anesthesiology) at the University of Padua. From 1998-2008 he was a Senior Group Leader for Neurodegeneration Research, Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, United Kingdom. Prior to that he held academic research positions in the Departments of Medicine and Biology at the University of California, San Diego. Dr. Skaper has authored/co-authored over 300 research papers, book chapters and monographs, as well as having guest-edited six journal thematic issues and two volumes of Methods in Molecular Biology on neurotrophic factors. He is Editor-in-Chief of CNS & Neurological Disorders Drug Targets, Associate Editor of the American Journal of Neuroprotection and Neuroregeneration, handling editor for Scientific Reports, and a Councilor of the International Association of Neurorestoratology. His research interests focus on the role of immune cells and their interactions in neuroinflammation, in particular with regards to neuropathic pain and multiple sclerosis, and the development of therapeutic strategies based on natural molecules. He is a member of Sigma ?I, Phi Lambda Upsilon, Alpha Chi Sigma, the Society for Neuroscience and the International Society of Cerebral Blood Flow and Metabolism.

Research Interest :

Neurodegenerative Disorders

OCM Member
President/CEO
International Institute of Medicine and Science , USA
Biography :

Dr. Alain L Fymat is a medical-physical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has extensively published (~ 400 publications including patents, books & monographs, book chapters, refereed articles) and has lectured extensively in the USA, Europe, Africa and Asia. He has been the recipient of numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is a Board member of several institutions and Health Advisor of the American Heart & Stroke Association (Coachella Valley Division, California). He is Editor-in-Chief, Honorable Editor or Editor of 25 scientific Journals

OCM Member
Chairman, Neurosurgery and Neuroengineering
Karolinska Institutet , Sweden
Biography :

Hans von Holst received his Medical Doctor´s degree in 1976 and specialist in Neurosurgery 1982 at Karolinska University Hospital. In 1985 he earned his PhD and Associate Professorship in Neurosurgery, Clinical Neuroscience at Karolinska Institutet. During 1991-1996 he was appointed as Chairman of the Dept of Neurosurgery and Division Manager of the Neuroclinics at Karolinska University Hospital, respectively. In 1995 he became Professor in Neuroengineering at the Royal Institute of Technology. He has published around 140 original papers in reputed journals, reviews and books and has been serving as an editorial board member in several journals.

Research Interest :

Neurosurgery and Neuroengineering

Allied Academies Global Conference Directory

Mail us at

Drop us a mail for program enquiry
dementia@alliedmeetings.com
Sponser/Exhibiting/advertising
dementia@alliedmeetings.com
General queries
dementia@alliedmeetings.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions


Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

Insurance

Registration fees do not include insurance of any kind.

Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.

Press/Media

Press permission must be obtained from allied academies Conferences Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The allied academies is an objective third-party nonprofit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact to request a personalized letter of invitation.
Regarding refunds, all bank charges will be for the registrants account.

Cancellation, Postponement and Transfer of Registration

Cancellation Policy

If an allied academy cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another allied academies event which must occur within one year from the date of cancellation.

Postponement

If allied academies   postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another e allied academies event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to dementia@alliedmeetings.com . Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies. if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.


Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.
Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.
Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied academies, including the inability to obtain a visa.

Refund Policy

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:
Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
Within 60-30 days of Conference: Eligible for 50% of payment Refund
Within 30 days of Conference: Not eligible for Refund
E-Poster Payments will not be refunded.

Accommodation Cancellation Policy

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.
 



Authorization Policy


Copyright © 2018-2019 Allied Academies, All Rights Reserved.